Delaware Analysis Shows GLP-1 Rebates Keep Drug Costs Stable Despite Increased Use
Delaware Department of Insurance analysis finds GLP-1 drug prices effectively stable after rebates, indicating limited impact on health insurance cost increases despite higher utilization.